Quent Capital, LLC Astrazeneca PLC Transaction History
Quent Capital, LLC
- $931 Million
- Q4 2024
A detailed history of Quent Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Quent Capital, LLC holds 1,360 shares of AZN stock, worth $101,224. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,360
Previous 1,387
1.95%
Holding current value
$101,224
Previous $108,000
17.59%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding AZN
# of Institutions
1,343Shares Held
477MCall Options Held
5.29MPut Options Held
3.79M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.68 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.05 Billion2.12% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.76 Billion0.46% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.74 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.45 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $231B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...